Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Tailored Treatment for H. Pylori Infection According to the Presence of DPO-PCR Based Clarithromycin Resistance

NCT04462133 is registered in ClinicalTrials.gov with Incheon St.Mary's Hospital as lead sponsor.

NCT NCT04462133
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04462133 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Tailored Treatment for H. Pylori Infection According to the Presence of DPO-PCR Based Clarithromycin Resistance
Lead sponsor
Incheon St.Mary's Hospital
Phase
Not applicable
Overall status
Withdrawn
Start date
September 1, 2020
Completion date
October 1, 2024
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic resistant infection, helicobacter pylori infection